OneOme
Minneapolis, US · Founded 2013 · Delaware LLC
OneOme is a precision medicine company that provides pharmacogenomics testing and analytics to healthcare providers, helping them optimize medication selection based on patients' genetic profiles. Co-founded by Mayo Clinic, the company serves healthcare teams and institutions globally seeking to improve patient outcomes and reduce costs through personalized medication decisions.
Founders & leadership
OneOme was founded in 2013 by Mayo Clinic.
MC
Mayo ClinicCo-founder
DJ
Danny J. CunagininExecutive
TD
Troy D. KoposchkeExecutive
JL
John Logan Black, IIINamed on SEC filing
MJ
Matthew J. FerberNamed on SEC filing
Board
JF
Jeremy FrieseBoard director
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 4 rounds · 2015–2017
▶$100KraisedJun 2017 · 1 investors · Other TechnologyRule 506(b)
▶$100KraisedJun 2017 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Keith StewartDirector
- Harlan LangstraatExecutive Officer, Director
- Jeremy L. FrieseDirector
- Mark E. SylvesterExecutive Officer
- Troy D. KopischkeDirector
- Paul J. OwenExecutive Officer
- Offering amount
- $5M
- Amount sold
- $100K
- Minimum investment
- $50K
- Proceeds to insiders
- $960K
- First sale
- Jun 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$2.1MraisedOct 2016 · 11 investors · Other TechnologyRule 506(b)
▶$2.1MraisedOct 2016 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark E. SylvesterExecutive Officer
- Paul J. OwenExecutive Officer
- Keith StewartDirector
- Troy D. KopischkeDirector
- Jeremy FrieseDirector
- Harlan LangstraatDirector
- Offering amount
- $3.5M
- Amount sold
- $2.1M
- Minimum investment
- $40K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$530KraisedOct 2016 · 11 investors · Other TechnologyRule 506(b)
▶$530KraisedOct 2016 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul J. OwenExecutive Officer
- Keith StewartDirector
- Mark E. SylvesterExecutive Officer
- Jeremy FrieseDirector
- Troy D. KopischkeDirector
- Harlan LangstraatDirector
- Offering amount
- $600K
- Amount sold
- $530K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$1MraisedMay 2015 · 15 investors · Other TechnologyRule 506(b)
▶$1MraisedMay 2015 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John Logan Black, IIIDirector
- Jeremy FrieseDirector
- Matthew J. FerberDirector
- Danny J. CunaginExecutive Officer
- Troy D. KoposchkeExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Mar 2015
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through OneOme went on to found or lead other companies.
Competitors · 9
by search overlap
Myome34 shared keywordsMyOme provides genomic insights and clinical genetic screening reports to help individuals and healthcare providers assess risks for hereditary conditions and make informed health decisions.
Genomind24 shared keywordsGenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen. The platform serves healthcare providers and care teams to reduce prescribing errors, prevent adverse events, and optimize medication safety for complex polypharmacy cases.
One Medical21 shared keywordsNASDAQ: ONEM; acquired by Amazon
healthOme20 shared keywordsHealthŌme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
Labcorp20 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IDbyDNA19 shared keywordsScalable, high throughput DNA sequencing platforms.
Quest Diagnostics18 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Immunome18 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
Nucleome18 shared keywordsNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.
Companies competing with OneOme for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does OneOme do?
- OneOme is a precision medicine company that provides pharmacogenomics testing and analytics to healthcare providers, helping them optimize medication selection based on patients' genetic profiles. Co-founded by Mayo Clinic, the company serves healthcare teams and institutions globally seeking to improve patient outcomes and reduce costs through personalized medication decisions.
- Who founded OneOme?
- OneOme was founded by Mayo Clinic in 2013.
- How much funding has OneOme raised?
- OneOme has disclosed $3.8M raised across 4 rounds.
- Where is OneOme headquartered?
- OneOme is headquartered in Minneapolis, US.